Medical Device Commercialization - Mynosys Cellular Devices Background and Challenge: Mynosys Cellular Devices was formed to commercialize technologies developed by a UCSF professor of ophthalmology David Sretavan and Chris Keller PhD. to address a major challenge of cataract treatment – a repeatable, perfect capsulotomy. The other challenge John Hendrick, Mynosys CEO and the team faced was accelerating the commercialization process to g

Join for free to read